MARKET

VCEL

VCEL

Vericel
NASDAQ
32.29
-0.25
-0.75%
After Hours: 32.29 0 0.00% 16:10 03/16 EDT
OPEN
32.79
PREV CLOSE
32.54
HIGH
33.47
LOW
32.20
VOLUME
621.16K
TURNOVER
--
52 WEEK HIGH
48.75
52 WEEK LOW
29.24
MARKET CAP
1.64B
P/E (TTM)
101.96
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at VCEL last week (0309-0313)?
Weekly Report · 20h ago
Weekly Report: what happened at VCEL last week (0302-0306)?
Weekly Report · 03/09 10:36
MediWound Publishes Corporate Presentation on Next-Generation Enzymatic Therapies for Non-Surgical Tissue Repair
Reuters · 03/05 12:32
Vericel Chief Legal Officer Sean C. Flynn Disposes of Common Shares
Reuters · 03/04 21:06
Vericel COO Michael Halpin Disposes of Common Shares
Reuters · 03/04 21:06
FDA approves Vericel’s Burlington facility for MACI commercial manufacturing
Reuters · 03/04 13:06
Vericel announces U.S. FDA approval of new manufacturing facility
TipRanks · 03/04 13:05
Vericel Wins FDA Approval for New Burlington Cell Therapy Manufacturing Facility
Reuters · 03/04 13:01
More
About VCEL
Vericel Corporation is a fully-integrated, commercial-stage biopharmaceutical company. The Company is a provider of advanced therapies for the sports medicine and severe burn care markets. It markets three products in the United States. MACI (autologous cultured chondrocytes on porcine collagen membrane) is an autologous-cellularized scaffold product indicated for the repair of symptomatic, single or multiple full-thickness cartilage defects of the knee with or without bone involvement in adults. Epicel (cultured epidermal autografts) is a permanent skin replacement for the treatment of patients with deep dermal or full-thickness burns greater than or equal to 30% of total body surface area. The Company also holds a license for North American rights to NexoBrid (anacaulase-bcdb), a biological orphan product containing proteolytic enzymes, which is indicated for the removal of eschar in adult and pediatric patients with deep partial thickness and/or full-thickness thermal burns.

Webull offers Vericel Corp stock information, including NASDAQ: VCEL real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, VCEL stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading VCEL stock methods without spending real money on the virtual paper trading platform.